John Duncan Higgons, Chief Operating Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 20,000 shares at $50.09 ($1.0M) on 2015-12-15, disclosed to the SEC on 2015-12-17.
Scheduled sale ($1.0M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| JNCE | SELL | 2021-02-18 | $2K | — | Filing → |
| JNCE | SELL | 2021-01-22 | $20K | — | Filing → |
| JNCE | SELL | 2020-01-08 | $12K | — | Filing → |